MKK3/MKK4 inhibitors (Signal)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMKK3/MKK4 inhibitors (Signal)
Drug Alias NameMKK4 inhibitors (Signal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsNerve DegenerationAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research DivisionUniversity Of Massachusetts Medical School
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAutoimmune DiseasesPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A